Our Services
Medical Information
Helpful Resources
Published on: 10/11/2026
A low mean platelet volume (MPV) means your platelets are smaller than average, which often points to older platelets in circulation or reduced platelet production in the bone marrow. Common causes include iron deficiency or aplastic anemia, chronic kidney disease, inflammatory bowel disease, certain autoimmune conditions, chemotherapy effects, and some inherited platelet disorders, though a mildly low result can also be harmless on its own. Because MPV is interpreted alongside your platelet count, hemoglobin, and symptoms, the same number can mean very different things from person to person, so there are several important factors to consider below before drawing conclusions. If you are also noticing fatigue, easy bruising, frequent infections, unusual bleeding, or other changes, a free, instant, online symptom check can help you connect your lab result to what you are actually experiencing. It takes only a few minutes, is private, and gives you a clearer sense of which conditions fit your picture and whether you should follow up with a doctor soon.
Last reviewed for medical accuracy: 10/09/2026
A low mean platelet volume (MPV) result on your blood test can raise questions about your overall health. MPV measures the average size of your platelets—tiny cells in your blood that help with clotting. Understanding what a low MPV means, why it happens and what to do next can help you feel more in control and prepare you for a conversation with your doctor.
Platelets are small cell fragments in your bloodstream that stop bleeding by clumping and forming plugs in blood vessel injuries.
MPV reflects the average size of those platelets. On a standard complete blood count (CBC), MPV is reported in femtoliters (fL).
Smaller platelets may mean your bone marrow is producing fewer or less mature platelets, or your body is using platelets too quickly. A low MPV result itself isn’t a diagnosis—it’s a clue that prompts further investigation.
Platelet size can help your doctor distinguish between different causes of low platelet counts (thrombocytopenia) and guide treatment decisions.
A low mean platelet volume may occur in a variety of settings. Some of the most common causes include:
In many cases, a slightly low MPV by itself won’t cause symptoms. It’s a marker that your doctor will interpret alongside your platelet count, red and white blood cell counts, and your overall health picture.
A low MPV result on its own rarely causes symptoms. Instead, you might notice signs related to low platelet counts (thrombocytopenia):
If you experience any of these, especially if they come on suddenly or worsen, it’s important to get medical attention promptly.
When your MPV is low, your doctor typically will:
This stepwise approach helps rule in or out causes and avoids unnecessary invasive procedures.
Treatment depends on the underlying cause:
In many cases, addressing the root issue will normalize MPV over weeks to months. Your doctor will monitor your blood counts regularly to track progress.
While you follow your doctor’s plan, you can take steps to support healthy platelet production:
These general measures won’t replace medical treatment but can help your overall blood health.
A low MPV plus severe bleeding, rapid bruising, or signs of internal bleeding (such as black stools or blood in the urine) can be serious. In these situations:
Always treat potential bleeding emergencies seriously.
Your doctor will set a schedule for repeat blood tests based on your specific condition. Monitoring may include:
Keeping a record of your symptoms, medications and test results will help guide your follow-up visits.
If you’re unsure what your blood test results may mean or want to explore possible causes of your symptoms, you might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. This tool can help you gather information before speaking to your healthcare provider.
If you have any life-threatening symptoms or are worried about serious bleeding, speak to a healthcare professional right away. Monitoring and early intervention can help you manage a low MPV effectively.
(References)
* Román Jiménez MG, Yamazaki Nakashimada MA, Blancas Galicia L. [Wiskott-Aldrich syndrome]. Rev Alerg Mex. 2010 Sep-Oct;57(5):171-5. PMID: 21854728.
* Osman A, Hitzler WE, Meyer CU, Landry P, Corduan A, Laffont B, Boilard E, Hellstern P, Vamvakas EC, Provost P. Effects of pathogen reduction systems on platelet microRNAs, mRNAs, activation, and function. Platelets. 2015;26(2):154-63. doi: 10.3109/09537104.2014.898178. Epub 2014 Apr 21. PMID: 24749844; PMCID: PMC4364275.
* Korkmaz L, Baştuğ O, Ozdemir A, Korkut S, Karaca C, Akin MA, Gunes T, Kurtoglu S, Ozturk MA. The Efficacy of Propranolol in Retinopathy of Prematurity and its Correlation with the Platelet Mass Index. Curr Eye Res. 2017 Jan;42(1):88-97. doi: 10.3109/02713683.2016.1158272. Epub 2016 Jun 3. PMID: 27260268.
* Düzlü M, Karamert R, Tutar H, Şahin M, Türkcan A, Yılmaz M. Diagnostic role of neutrophil-lymphocyte ratio in oral cavity cancers. Niger J Clin Pract. 2018 Jan;21(1):49-53. doi: 10.4103/1119-3077.224796. PMID: 29411723.
* Zuo X, Kong W, Feng L, Zhang H, Meng X, Chen W. Elevated platelet distribution width predicts poor prognosis in hepatocellular carcinoma. Cancer Biomark. 2019;24(3):307-313. doi: 10.3233/CBM-182076. PMID: 30829614; PMCID: PMC13082515.
* Hernández B, Fuentes E, Palomo I, Alarcón M. Increased platelet function during frailty. Exp Hematol. 2019 Sep;77:12-25.e2. doi: 10.1016/j.exphem.2019.08.006. Epub 2019 Aug 30. PMID: 31476327.
* Liu L, Zhao Y, Cui J, Chen S, Shi B. Evaluation of platelet distribution width as a diagnostic and prognostic biomarker in bladder neoplasm. Future Oncol. 2019 Nov;15(33):3797-3807. doi: 10.2217/fon-2019-0441. Epub 2019 Sep 18. PMID: 31532234.
* Botelho J, Machado V, Hussain SB, Zehra SA, Proença L, Orlandi M, Mendes JJ, D'Aiuto F. Periodontitis and circulating blood cell profiles: a systematic review and meta-analysis. Exp Hematol. 2021 Jan;93:1-13. doi: 10.1016/j.exphem.2020.10.001. Epub 2020 Oct 15. PMID: 33068648.
* Chen X, Wang C, Sun N, Pan S, Li R, Li X, Zhao J, Tong H, Tang Y, Han J, Qiao J, Qiu H, Wang H, Yang J, Ikezoe T. Aurka loss in CD19(+) B cells promotes megakaryocytopoiesis via IL-6/STAT3 signaling-mediated thrombopoietin production. Theranostics. 2021;11(10):4655-4671. doi: 10.7150/thno.49007. Epub 2021 Mar 4. PMID: 33754019; PMCID: PMC7978311.
* Collins J, Astle WJ, Megy K, Mumford AD, Vuckovic D. Advances in understanding the pathogenesis of hereditary macrothrombocytopenia. Br J Haematol. 2021 Oct;195(1):25-45. doi: 10.1111/bjh.17409. Epub 2021 Mar 30. PMID: 33783834.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.